Atlas Trials

Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers

Clinical trial NCT05370950 · COMPLETED

Trial details

NCT number
NCT05370950
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypercholesterolemia and Hyperlipidemia
Start date
2022-05-25
Primary completion
2022-12-31
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.